← Alignment Healthcare, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net Income — — — ($149.5m) ($148.0m) ($128.0m) ($724k)
Net Income From Continuing Operations — — — ($149.6m) ($148.2m) ($128.1m) ($978k)
Depreciation and amortization $16.6m $15.5m $16.0m $17.5m $21.7m $27.1m $30.5m
Amortization-debt issuance costs $1.9m $2.2m $2.3m $1.9m $1.3m $1.3m $1.8m
Amortization-investment discount — — — $0 ($4.9m) ($2.6m) ($1.3m)
Amortization Cash Flow — — — $386k $226k $702k $634k
Amortization Of Intangibles — — — $386k $226k $702k $634k
Amortization Of Securities — — — $0 ($4.9m) ($2.6m) ($1.3m)
Depreciation Amortization Depletion — — — $17.5m $21.7m $27.1m $30.5m
Gain on sale of property and equipment $418k $1.0m $0 $101k $0 $0 ($72k)
Loss on extinguishment of debt — $0 $0 $2.2m $0 $3.0m $0
Net loss ($44.7m) ($22.9m) ($195.3m) ($149.6m) ($148.2m) ($128.1m) ($978k)
Provision for credit loss $1.4m $118k $111k $150k $91k $123k $833k
(Gain) loss on right of use assets — — $0 $510k ($289k) $143k $0
Equity-based compensation — — — $81.7m $66.8m $71.1m $62.1m
Non-cash lease expense $0 $2.3m $2.7m $2.8m $2.3m $1.8m $1.6m
Accounts receivable ($5.8m) ($4.6m) ($17.6m) ($34.4m) ($26.9m) ($34.3m) ($100.1m)
Prepaid expenses and other current assets ($2.7m) ($12.0m) ($10.3m) ($14.4m) ($2.9m) $7.9m ($57.1m)
Other assets $1.2m $2.8m $644k ($86k) ($142k) $60k ($50k)
Medical expenses payable $36.6m $6.5m $12.5m $44.2m $35.3m $84.4m $184.8m
Accounts payable and accrued expenses $1.3m $645k $437k $13.7m ($6.3m) ($1.5m) $10.4m
Accrued compensation ($196k) $12.7m ($1.2m) $3.6m $6.6m $5.8m $9.1m
Lease liabilities $0 $1.3m ($3.8m) ($4.2m) ($3.5m) ($1.5m) ($1.5m)
Sale of property and equipment $0 $100k $0 $0 $0 $14k $75k
Sale of business — — — — $0 $0 $1.1m
Acquisition of property and equipment, net $0 $100k $0 ($23.8m) ($36.0m) ($41.4m) ($26.8m)
Payment of employment taxes related to release of restricted stock — — — $0 $0 ($350k) $0
Proceeds from exercise of stock options — — — $0 $0 $155k $18.1m
Acquisition of property in accounts payable $366k $106k $347k $505k $0 $70k $97k
Debt issuance costs in accounts payable — — — $0 $0 $512k $0
Restricted cash in other assets $0 $500k $1.8m $1.8m $2.0m $2.1m $2.1m
Beginning Cash Position — — — $468.4m $411.3m $205.0m $434.9m
Cash Flow From Continuing Financing Activities — — — $16.6m $105k $156.0m $18.0m
Cash Flow From Continuing Investing Activities — — — ($28.2m) ($147.3m) $39.2m ($15.0m)
Change In Account Payable — — — $13.7m ($6.3m) ($1.5m) $10.4m
Change In Accrued Expense — — — ($10.5m) $6.6m $5.8m $9.1m
Change In Interest Payable — — $0 ($14.1m) $0 $0 —
Change In Other Current Assets — — — ($86k) ($142k) $60k ($50k)
Change In Other Current Liabilities — — — ($4.2m) ($3.5m) ($1.5m) ($1.5m)
Change In Other Working Capital — — ($1.2m) $3.6m — — —
Change In Payable — — — $58.0m $28.9m $82.9m $195.1m
Change In Payables And Accrued Expense — — — $47.5m $35.5m $88.7m $204.2m
Change In Prepaid Assets — — — ($14.4m) ($2.9m) $7.9m ($57.1m)
Change In Receivables — — — ($34.4m) ($26.9m) ($34.3m) ($100.1m)
Change In Working Capital — — — ($5.6m) $2.0m $60.9m $45.5m
Changes In Account Receivables — — — ($34.4m) ($26.9m) ($34.3m) ($100.1m)
Changes In Cash — — — ($57.1m) ($206.3m) $230.0m $143.0m
End Cash Position — — — $411.3m $205.0m $434.9m $577.9m
Financing Cash Flow — — — $16.6m $105k $156.0m $18.0m
Free Cash Flow — — — ($69.2m) ($95.2m) ($6.6m) $113.1m
Gain Loss On Sale Of PPE — — — $611k ($289k) $134k ($72k)
Investing Cash Flow — — — ($28.2m) ($147.3m) $39.2m ($15.0m)
Issuance Of Capital Stock — — $390.6m $0 $0 — —
Net Business Purchase And Sale — — — ($4.0m) $0 $0 $1.1m
Net PPE Purchase And Sale — — — ($23.8m) ($36.0m) ($41.4m) ($26.7m)
Operating Gains Losses — — — $2.8m ($289k) $3.2m ($72k)
Other Non Cash Items — — — $7.6m $3.6m $3.1m $3.4m
Proceeds From Stock Option Exercised — — — $0 $0 $155k $18.1m
Provisionand Write Offof Assets — — — $150k $91k $123k $833k
Purchase Of Business — — $0 ($4.0m) $0 $0 —
Purchase Of PPE — — — ($23.8m) ($36.0m) ($41.4m) ($26.8m)
Repurchase Of Capital Stock — — ($1.5m) $0 $0 — —
Sale Of PPE — — — $0 $0 $14k $75k
Stock Based Compensation — — — $81.7m $66.8m $71.1m $62.1m
Net cash provided by (used in) operating activities $9.2m $7.6m ($78.8m) ($45.4m) ($59.2m) $34.8m $139.9m
Capital Expenditure — — — ($23.8m) ($36.0m) ($41.4m) ($26.8m)
Purchase of investments ($320k) ($1.6m) ($2.5m) ($2.8m) ($379.1m) ($82.2m) ($65.6m)
Net Investment Purchase And Sale — — — ($400k) ($111.3m) $80.6m $10.7m
Purchase Of Investment — — — ($2.8m) ($379.1m) ($82.2m) ($65.6m)
Maturities of investments — — — $2.4m $267.8m $162.8m $76.3m
Sale Of Investment — — — $2.4m $267.8m $162.8m $76.3m
Net cash provided by (used in) investing activities ($10.2m) ($16.4m) ($20.8m) ($28.2m) ($147.3m) $39.2m ($15.0m)
Proceeds from long-term debt $55.0m $0 $0 $165.0m $0 $380.0m $0
Debt issuance costs ($854k) $0 $0 ($5.2m) $0 ($8.8m) ($26k)
Issuance Of Debt — — — $165.0m $0 $380.0m $0
Long Term Debt Issuance — — — $165.0m $0 $380.0m $0
Net Issuance Payments Of Debt — — — $21.8m $0 $165.0m $0
Net Long Term Debt Issuance — — — $21.8m $0 $165.0m $0
Repayment of long-term debt — $0 $0 ($143.2m) $0 ($215.0m) $0
Long Term Debt Payments — — — ($143.2m) $0 ($215.0m) $0
Repayment Of Debt — — — ($143.2m) $0 ($215.0m) $0
Common Stock Issuance — — $390.6m $0 $0 — —
Net Common Stock Issuance — — $389.1m $0 $0 — —
Common Stock Payments — — ($1.5m) $0 $0 — —
Contributions from noncontrolling interest holders — $0 $15k $68k $105k $15k $0
Net Other Financing Charges — — — ($5.2m) $105k ($9.1m) ($26k)
Net cash provided by financing activities $52.7m $130.1m $360.1m $16.6m $105k $156.0m $18.0m
Net increase (decrease) in cash $51.6m $121.3m $260.5m ($57.1m) ($206.3m) $230.0m $143.0m
Cash, cash equivalents and restricted cash at beginning of period $86.5m $207.8m $468.4m $411.3m $205.0m $434.9m $577.9m
Cash and cash equivalents $86.5m $207.3m $466.6m $409.5m $202.9m $432.9m $575.8m
Change In Cash Supplemental As Reported — — — ($57.1m) ($206.3m) $230.0m $143.0m
Cash paid for interest $9.5m $10.7m $11.0m $22.4m $19.2m $22.2m $13.8m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.